R.Y. Lei
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Breast Cancer Treatment Studies 7
-
- Monoclonal and Polyclonal Antibodies Research 2
- Advances in Oncology and Radiotherapy 2
- Co-authors
- Anne M. Ercolini (2 shared papers)R. Todd Reilly (2 shared papers)Elizabeth M. Jaffee (2 shared papers)Jean-Pascal Machiels (2 shared papers)Leisha A. Emens (2 shared papers)Francesca I. Okoye (2 shared papers)K. V. Shah (1 shared paper)J E Mok (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)Frontiers in Oncology (1 paper)Prostate International (1 paper)Journal of Surgical Oncology (1 paper)Environmental Health (1 paper)
- Partner nations
- United StatesChinaCzechia
In The Last Decade
R.Y. Lei
12 papers receiving 676 citations
Peers
Comparison fields: 5 of 52
- Immunology 425
- Oncology 349
- Cancer Research 89
- Genetics 148
- Radiology, Nuclear Medicine and Imaging 92
Countries citing papers authored by R.Y. Lei
This map shows the geographic impact of R.Y. Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.Y. Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.Y. Lei more than expected).
Fields of papers citing papers by R.Y. Lei
This network shows the impact of papers produced by R.Y. Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.Y. Lei. The network helps show where R.Y. Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside R.Y. Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. | 2001 | 364 |
| 2 | Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. | 1997 | 126 |
| 3 | The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors. | 2001 | 122 |
| 4 | 2013 | 31 | |
| 5 | 2015 | 30 | |
| 6 | 2014 | 9 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 6 | |
| 9 | 2025 | 1 | |
| 10 | 2015 | 1 | |
| 11 | 2013 | 1 | |
| 12 | 2012 | 1 | |
| 13 | 2011 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About R.Y. Lei
R.Y. Lei is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine and Radiation, having authored 15 papers that have together received 699 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Advanced Radiotherapy Techniques (3 papers), Global Cancer Incidence and Screening (3 papers), Immunotherapy and Immune Responses (2 papers), Cancer Diagnosis and Treatment (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Advances in Oncology and Radiotherapy (2 papers) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Immunology (425 citations), Oncology (349 citations), Cancer Research (89 citations), Genetics (148 citations) and Radiology, Nuclear Medicine and Imaging (92 citations). R.Y. Lei has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Anne M. Ercolini, R. Todd Reilly, Elizabeth M. Jaffee, Jean-Pascal Machiels, Leisha A. Emens, Francesca I. Okoye, K. V. Shah, J E Mok, Rong Wu and Denise C. Connolly. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Frontiers in Oncology, Prostate International, Journal of Surgical Oncology and Environmental Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.